Document is current
Any future updates will be listed below
-
Authors
Di Pietro, Andrea
Polmear, Jack https://orcid.org/0000-0003-3449-4128
Cooper, Lucy
Damelang, Timon https://orcid.org/0000-0002-6150-4435
Hussain, Tabinda
Hailes, Lauren
O’Donnell, Kristy
Udupa, Vibha
Mi, Tian
Preston, Simon https://orcid.org/0000-0001-8969-8297
Shtewe, Areen
Hershberg, Uri
Turner, Stephen J. https://orcid.org/0000-0002-1002-0000
La Gruta, Nicole L. https://orcid.org/0000-0001-5358-9363
Chung, Amy W. https://orcid.org/0000-0003-0020-9704
Tarlinton, David M. https://orcid.org/0000-0001-9928-686X
Scharer, Christopher D. https://orcid.org/0000-0001-7716-8504
Good-Jacobson, Kim L. https://orcid.org/0000-0003-1891-7274
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1108066, 1140509, 1182086, 1054925, 1175411, 1183478)
American Association of Immunologists
Department of Education and Training | Australian Research Council (FT170100174, DP200102776, DP170102020)
EC | Horizon 2020 Framework Programme (825821)
U.S. Department of Health & Human Services | National Institutes of Health (A1106697)
Bellberry Ltd
- License Information
-
More Information
Article History
Received: 20 January 2021
Accepted: 20 October 2021
First Online: 29 November 2021
Competing interests
: K.L.G.-J. has received funding from GSK for a separate project. The remaining authors declare no competing interests.
